Equities researchers at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Sorrento Therapeutics stock opened at $0.01 on Monday. The business has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.02. Sorrento Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.25.
About Sorrento Therapeutics
Read More
- Five stocks we like better than Sorrento Therapeutics
- How to Capture the Benefits of Dividend Increases
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Comparing and Trading High PE Ratio Stocks
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- What does consumer price index measure?
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.